S. Ohbayashi

Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.

S. Perrey, J. Binet, A. Edgar, 2001, Atherosclerosis.

Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.

N. Abe, N. Ashizawa, A. Matsuura, 1997, Japanese journal of pharmacology.

Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.

N. Ashizawa, A. Matsuura, Y. Sugiyama, 1998, Diabetes research and clinical practice.

[Experimental studies on gastric ulcer (5). Endoscopical evaluation of healing processes of acetic acid ulcer in rats (1). Ulcer reducing process].

M. Uchida, K. Fukawa, O. Kawano, 1983, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

抗高脂血症薬フェノフィブラートの抗動脈硬化作用(I)コレステロール負荷ウサギにおける血清脂質低下作用を介さない抗動脈硬化作用

T. Mori, H. Kasai, T. Nagayama, 1995 .